These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 11030494

  • 1. Novel antidepressant strategies to optimize outcome.
    J Clin Psychiatry; 2000 Sep; 61(9):686-96. PubMed ID: 11030494
    [No Abstract] [Full Text] [Related]

  • 2. Introduction. Reboxetine: a new selective antidepressant for the treatment of depression.
    Montgomery SA, Schatzberg AF.
    J Clin Psychiatry; 1998 Sep; 59 Suppl 14():3. PubMed ID: 9818622
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of serotonin and noradrenaline in social dysfunction: a review of data on reboxetine and the Social Adaptation Self-evaluation Scale (SASS).
    Keller M.
    Gen Hosp Psychiatry; 2001 Sep; 23(1):15-9. PubMed ID: 11226552
    [Abstract] [Full Text] [Related]

  • 7. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.
    Dubini A, Bosc M, Polin V.
    J Psychopharmacol; 1997 Sep; 11(4 Suppl):S17-23. PubMed ID: 9438229
    [Abstract] [Full Text] [Related]

  • 8. [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline].
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):56. PubMed ID: 15526675
    [No Abstract] [Full Text] [Related]

  • 9. Reboxetine treatment of depression in Parkinson's disease.
    Lemke MR.
    J Clin Psychiatry; 2000 Nov 08; 61(11):872. PubMed ID: 11105742
    [No Abstract] [Full Text] [Related]

  • 10. Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine.
    Nelson JC, Portera L, Leon AC.
    J Clin Psychiatry; 2005 Nov 08; 66(11):1409-14. PubMed ID: 16420078
    [Abstract] [Full Text] [Related]

  • 11. Rapid improvement in affective information processing after acute administration of reboxetine.
    Thase ME.
    Am J Psychiatry; 2009 Oct 08; 166(10):1096-9. PubMed ID: 19797440
    [No Abstract] [Full Text] [Related]

  • 12. The role of norepinephrine in the treatment of depression.
    J Clin Psychiatry; 1999 Sep 08; 60(9):623-31. PubMed ID: 10520985
    [No Abstract] [Full Text] [Related]

  • 13. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.
    Hajós M, Fleishaker JC, Filipiak-Reisner JK, Brown MT, Wong EH.
    CNS Drug Rev; 2004 Sep 08; 10(1):23-44. PubMed ID: 14978512
    [Abstract] [Full Text] [Related]

  • 14. Do noradrenaline and serotonin differentially affect social motivation and behaviour?
    Dubini A, Bosc M, Polin V.
    Eur Neuropsychopharmacol; 1997 Apr 08; 7 Suppl 1():S49-55; discussion S71-3. PubMed ID: 9169310
    [Abstract] [Full Text] [Related]

  • 15. The impact of antidepressant use on social functioning: reboxetine versus fluoxetine.
    Venditti LN, Arcelus A, Birnbaum H, Greenberg P, Barr CE, Rowland C, Williamson T.
    Int Clin Psychopharmacol; 2000 Sep 08; 15(5):279-89. PubMed ID: 10993130
    [Abstract] [Full Text] [Related]

  • 16. The need for new and better antidepressants: reboxetine a new option.
    Dencker SJ.
    Acta Psychiatr Scand Suppl; 2000 Sep 08; 402():6-11. PubMed ID: 10901153
    [Abstract] [Full Text] [Related]

  • 17. Reboxetine--another new antidepressant.
    Drug Ther Bull; 1998 Nov 08; 36(11):86-8. PubMed ID: 10562766
    [Abstract] [Full Text] [Related]

  • 18. Effect of reboxetine on major depressive disorder in breast cancer patients: an open-label study.
    Grassi L, Biancosino B, Marmai L, Righi R.
    J Clin Psychiatry; 2004 Apr 08; 65(4):515-20. PubMed ID: 15119914
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antidepressant efficacy and tolerability of the selective norepinephrine reuptake inhibitor reboxetine: a review.
    Burrows GD, Maguire KP, Norman TR.
    J Clin Psychiatry; 1998 Apr 08; 59 Suppl 14():4-7. PubMed ID: 9818623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.